UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001583
Receipt No. R000001771
Scientific Title Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer
Date of disclosure of the study information 2008/12/17
Last modified on 2018/05/14 16:40:19

No. Disposal Last modified on Item of update
1 Insert 2008/12/17 08:34:13
2 Update 2008/12/19 14:22:45 Public title
Acronym
3 Update 2008/12/19 14:27:52 Narrative objectives1
Primary outcomes
Key secondary outcomes
4 Update 2008/12/19 14:39:16 Interventions/Control_1
Key inclusion criteria
Key exclusion criteria
5 Update 2010/06/17 09:49:33 Recruitment status
6 Update 2010/08/04 15:20:19 Recruitment status
7 Update 2010/08/04 15:21:55 Division name
Address
8 Update 2011/07/26 11:24:14 Post marketing survey by drug manufacture etc., specified by Japanese law.
9 Update 2018/05/14 16:40:19 Email
Address
Address
TEL
Email
Name of primary sponsor
Organization


Contact us.